Floatz logo

L-Bupivacaine

Wound Infusion

Fondazione IRCCS Policlinico San Matteo di PaviaSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Wound Infusion cohort.

Asset / SponsorPhaseRating
Patrol
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 4BB
NEPENTHE
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 4BB

Same molecule, other indications

L-Bupivacaine is also rated in:

Lymph Node DissectionDormant
BB
Indicative ·
68 / 100
View asset →
Surgical Wound InfiltrationDormant
BB
Indicative ·
68 / 100
View asset →
breast cancerDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →